PFE

Pfizer
D

PFE

Arincen59/100B

Pfizer price to sales (P/S) ratio

Pfizer's P/S ratio is 2.63: its market cap of 167.51B USD over revenue of 63.62B USD in the last twelve months.

Today
2.63
Average, 5 years
2.66
Low, 5 years
1.92
High, 5 years
5.66

P/S ratio = market cap ÷ revenue (last 12 months) = 167.51B ÷ 63.62B = 2.63

Each day's market cap over the revenue of the last four quarters reported by that day.

P/S ratio by year and by quarter

Fiscal yearPeriod endingP/S ratioMarket capRevenue
Today2.63167.51B63.62B
FY202531 Dec 20252.26141.50B62.58B
FY202431 Dec 20242.36150.27B63.63B
FY202331 Dec 20232.73162.46B59.55B
FY202231 Dec 20222.84287.35B101.18B
FY202131 Dec 20214.07330.74B81.29B
FY202031 Dec 20204.91204.48B41.65B
FY201931 Dec 20195.06206.83B40.91B
FY201831 Dec 20185.95242.98B40.83B
FY201731 Dec 20173.90204.95B52.55B
FY201631 Dec 20163.55187.48B52.82B
FY201531 Dec 20153.87188.99B48.85B
FY201431 Dec 20143.78187.40B49.61B
FY201331 Dec 20133.84197.85B51.58B
FY201231 Dec 20123.24176.90B54.66B
FY201131 Dec 20112.63160.33B61.04B
FY201031 Dec 20102.05133.40B65.17B
FY200931 Dec 20092.42120.80B50.01B
FY200831 Dec 20082.34112.95B48.30B
FY200731 Dec 20073.08149.06B48.42B
FY200631 Dec 20063.68177.79B48.37B
FY200531 Dec 20053.43162.75B47.41B
FY200431 Dec 20043.92191.97B48.99B
FY200331 Dec 20035.40241.56B44.74B
FY200231 Dec 20025.52178.40B32.29B
FY200131 Dec 20018.12235.71B29.02B
FY200031 Dec 20009.23270.82B29.36B
FY199931 Dec 19996.88188.37B27.38B
FY199831 Dec 19986.44149.55B23.23B
FY199731 Dec 19978.1389.89B11.06B
FY199631 Dec 19964.9348.63B9.86B
FY199531 Dec 19953.7537.56B10.02B
FY199431 Dec 19942.7422.68B8.28B
FY199331 Dec 19932.8221.08B7.48B
FY199231 Dec 19923.0622.13B7.23B
FY199131 Dec 19913.6325.24B6.95B
FY199031 Dec 19901.9012.17B6.41B
FY198931 Dec 19892.1011.92B5.67B
FY198831 Dec 19881.779.54B5.39B
FY198731 Dec 19871.527.47B4.92B
FY198631 Dec 19862.229.94B4.48B
FY198531 Dec 19852.068.28B4.02B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Pfizer's P/S ratio

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.